Results 271 to 280 of about 872,383 (328)

The effects of leukodepletion on the generation and removal of microvesicles and prion protein in blood components

Transfusion, 2006
BACKGROUND:  Universal leukodepletion (LD) has been implemented in the United Kingdom to reduce the risk of transfusion‐transmitted variant Creutzfeldt‐Jakob disease. If LD causes microvesiculation of blood cells, however, potentially infectious membrane‐associated prion could reach the final products.STUDY DESIGN AND METHODS:  We have measured ...
Pranee Krailadsiri, Jerard Seghatchian, Ian MacGregor, O. Drummond, Rachel M. Perrin, Frances A. Spring, R.J. Prescott, Lorna M. Williamson, C. V. Prowse, David J. Anstee, Marc Turner   +10 more
openalex   +3 more sources

Evaluation of HTLV‐I removal by filtration of blood cell components in a routine setting

Transfusion, 2004
BACKGROUND:  WBC depletion by filtration may prevent the transmission of HTLV‐I, which requires cell‐to‐cell contact. The removal of HTLV‐I‐infected cells in routinely filtered blood cell components was measured.STUDY DESIGN AND METHODS:  The study was conducted in Martinique where systematic screening for HTLV‐I and ‐II and universal leukoreduction ...
Raymond Césaire, B. Kérob‐Bauchet, Olivier Bourdonné, H. Maier, Karim Ould Amar, Philippe Halbout, Axelle Dehée, Nathalie Désiré, Fabienne Dantin, Odile Béra, Agnès Lézin   +10 more
openalex   +3 more sources

Prevention of primary transfusion‐associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high‐affinity filters

British Journal of Haematology, 1994
Summary. A prospective study was carried out to determine whether use of cytomegalovirus (CMV) unscreened red blood cells and platelet concentrates, white blood cell (WBC) depleted with high‐efficiency filters, would prevent transfusion‐associated (TA) CMV infection in CMV seronegative bone marrow transplant recipients.
H. C. van Prooijen, J. Visser, W. R. van Oostendorp, G C de Gast, Leo F. Verdonck   +4 more
openalex   +3 more sources

The source and removal of microaggregates in aged human blood and human blood components

Journal of the American College of Emergency Physicians, 1977
Alfred S. Gervin, K. G. Mason, Robert F. Buckman   +2 more
openalex   +2 more sources

The source and removal of microaggregates in aged human blood and human blood components

The Journal of Trauma: Injury, Infection, and Critical Care, 1976
Alfred S. Gervin, David C. Colletti, DAVID B. PILCHER   +2 more
openalex   +2 more sources

[The efficiency of a new porous type leukocyte removal filter for red cell blood components, Terumo Imuguard III-RC, in the rapid transfusion conditions].

Masui. The Japanese journal of anesthesiology, 1997
We evaluated the efficiency of a new porous type leukocyte removal filter for red cell blood components, Terumo Imuguard III-RC, in the rapid transfusion conditions. One leukocyte removal filter was used for 2 units of RC-M.A.P (red cell mannitol-adenine-phosphate).
Shizuo Kajiyama, Motonao Nakao, Ryoichi Kawaguchi, Kou Nakatani, Yuji Okada, Keita Hazama, H Unetani, C Hanaki   +7 more
openalex   +2 more sources

PARTI: INFECTIOUS AGENTS AND THEIR REMOVAL FROM BLOOD AND BLOOD COMPONENTS

, 1995

openalex   +2 more sources

The effects of leucocyte depletion on the generation and removal of microvesicles and prion related protein in blood components

Transfusion and Apheresis Science, 2001
Pranee Krailadsiri, Rachel J. Perry, O. Drummond, Kim S. Smith, D. J. Hockley, J Seghatchian, Frances A. Spring, Ian MacGregor, Lorna M. Williamson, C. V. Prowse, A. Lubenko, David J. Anstee, Trevor W. Barrowcliffe, Marc Turner   +13 more
openalex   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Bioactive components and molecular mechanisms of Salvia miltiorrhiza Bunge in promoting blood circulation to remove blood stasis

Journal of Ethnopharmacology, 2023
Salvia miltiorrhiza Bunge (SM) is an outstanding herbal medicine with various traditional effects, especially promoting blood circulation to remove blood stasis. It has been widely used for centuries to treat blood stasis syndrome (BSS)-related diseases.
Baoyu Wei, Chengtao Sun, Haitong Wan, Qiyang Shou, Bing Han, Miaomiao Sheng, Liqing Li, Guoyin Kai   +7 more
openaire   +2 more sources

[The rate of removal from circulating blood and binding with plasma components of exogenous histone].

Voprosy meditsinskoi khimii, 1975
Goriukhina Oa, Ashmarin Ip
openalex   +2 more sources